LMF Acquisition Opportunities SPAC Merges with SeaStar Medical in $85 Million Medical Technology Deal

May 3, 2022

Skyway Capital Markets is advising on the proposed merger of SeaStar Medical, a medical technology company developing extracorporeal immunomodulatory therapies, with LMF Acquisition Opportunities, Inc. (Nasdaq: LMAO), a publicly traded special purpose acquisition company. The transaction is expected to give SeaStar Medical access to capital markets to accelerate development of its lead program for acute kidney injury (AKI) and advance additional acute and chronic indications.

Buyers
LMF Acquisition Opportunities, Inc. (Nasdaq: LMAO)
Targets
SeaStar Medical, Inc.
Industry
Medical Devices
Location
Colorado, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.